“Incompetence, racism and prejudice delayed my diagnosis”
Women and Parkinson's
Author: Manon DayPublished: 23 January 2020
Prep: Cook: Serves:
It took a decade for Manon Day to be diagnosed with
Parkinson’s – with clinicians treating her as though she was a drug addict,
causing her to feel “mistreated” and “powerless”. She explains the role being a
young black woman played in her delayed diagnosis – and why “we need more
awareness to break the myths and stereotypes” around who the condition affects
My Parkinson’s symptoms started at the age of 17, but it
wasn’t until 10 years later that I was diagnosed with the condition, aged 27.
Over the years, I was living with uncertainty and was
worried about my physical state. At first, I struggled with low blood pressure
and I was fainting several times a week. Now, my symptoms include stiffness,
difficulty moving, speech problems, bladder dysfunction, fatigue and more.
When I was officially diagnosed with Parkinson’s in 2011,
I was overwhelmed and in shock – it had taken a decade to get the right
diagnosis. I knew for sure that Parkinson’s was going to change everything.
Women are less likely to be diagnosed with Parkinson’s
compared to men. Being a young black woman played a huge role in my delayed
diagnosis. The neurologists I initially consulted stigmatised me. They didn’t
believe me when I explained my symptoms: they thought I was a drug addict. I
was mistreated and my experience was horrible. It reached the point where I
became very ill and could not walk because my body was so stiff. Racism was the
cause of my delayed diagnosis and I felt powerless.
Due to incompetence and prejudice, I did not receive the
medical care that I so desperately needed. Every time the paramedics rushed me
to the hospital emergency room, the neurologists sent me back home right away.
Consequently, I felt distressed and abandoned by the healthcare system.
I changed hospitals and thankfully, as of now, I receive the best medical care and treatment at the Montreal Neurological Institute and Hospital. I have had an excellent response to levodopa and through medication, diet and exercise, I’m managing my Parkinson’s.
“It’s a devastating diagnosis to receive in the
prime of your life”
When I told my family about my diagnosis, they were stunned, as we thought that the condition usually afflicts the elderly. We started researching it intensely. Although my movement disorder specialist gave me lots of information about Parkinson’s, I had no knowledge about how the condition affects women in general – for example how I experience more symptoms of rigidity and slowness during my periods.
There were several challenges related to my young onset
diagnosis: I couldn’t pursue my studies in the field of translation, and I
chose not to conceive children because pregnancy is a risk to my health. In
addition to my Parkinson’s, I live with a second rare disease called acromegaly,
which I was diagnosed with in 2014. It’s a hormonal disorder that affects
approximately 2,000 people in Canada. It’s a damaging and incurable disease and,
as far as I know, I am the only person in the world living with both young
onset Parkinson’s and acromegaly.
Parkinson’s has also had negative effects on my hobbies and social life – it’s a devastating diagnosis to receive in the prime of your life when you are full of plans for the future.
“Parkinson’s doesn’t only affect old Caucasian
Generally speaking, women and people from minority backgrounds are underrepresented in the Parkinson’s research community. I am registered in a clinical Parkinson’s trial database called the Quebec Parkinson’s Network because I want to be involved and share my experience to advance knowledge in the scientific community. I think playing a small role can have a positive impact in the development of future therapies.
I’ve never met other black men or women with Parkinson’s in Montreal – and while I’m in contact with a few people online, I don’t know the details of their personal stories. It’s a sad reality that minorities face several challenges to get diagnosed correctly with Parkinson’s. That’s why three years ago I created a Facebook group called Everything about Parkinson’s Disease to connect with fellow patients, young or old – and of different races. It now has over 9,000 members worldwide. Running the group gives me a sense of purpose and I’m very happy to make a difference in people’s lives.
We need more awareness to break the myths and stereotypes around the condition. Parkinson’s doesn’t only affect old Caucasian men. It can impact anyone, regardless of age or ethnicity.
Need to know: Manon Day is 35 years old and lives in Montreal, Canada. She was diagnosed with Parkinson’s in 2011, age 27, and subsequently quit her studies in translation. She is now a Parkinson’s campaigner and runs a Facebook group called Everything about Parkinson’s Disease to raise awareness of the condition and how it can affect people of all backgrounds.
The facts: who does Parkinson’s affect?
Parkinson’s affects people of all racial and ethnic backgrounds and cultures
Around 10 million people across the globe live with the condition – and by 2040, it is estimated that there will be 13 million people with Parkinson’s
Our ‘In My Country’ series features interviewees from organisations around the world to spotlight the differing experiences of and attitudes towards people with Parkinson’s globally
Women and Parkinson’s: Our campaign
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Each week, we’ll be sharing the little-heard stories of women with the condition to find out how their lives are being affected by a shocking data gap when it comes to women and Parkinson’s. This is just the start.
We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
Join us – #WomenAndParkinsons.
For more information on women and Parkinson’s please visit the EPDA website.
If you have a story to tell about being a woman with Parkinson’s – or some information about the impact of the condition on women for us to share with the global Parkinson’s community – please get in touch.
Can tremor predict the effect of Parkinson’s disease medication?
Researchers from the Netherlands have found a link between tremor symptoms and how dopaminergic medication impacts learning abilities in Parkinson’s disease. Many people with Parkinson’s become sensitive to learning through rewards due to a decrease in dopamine in the brain. As part of a new study – published in the scientific journal Brain –researchers assessed 43 tremor-dominant and 20 non-tremor dominant people with Parkinson’s while they were on and off dopaminergic medication. The results showed that in people with Parkinson’s who do not experience tremor, dopaminergic medication improves the ability to learn from rewards – and in those with tremor, the medication has no impact on reward learning. Rick Helmich, co-author of the study and a neurologist at Radboud University Medical Centre, the Netherlands, said: “Whether someone experiences tremor or not might therefore potentially have a significant predictive value regarding the effectiveness of medication in the cognitive domain. However, more…
Could a ‘Mediterranean diet’ lower the risk of Parkinson’s for women?
A study by scientists in Sweden has suggested that women who eat a ‘Mediterranean diet’ at middle age could have a lower risk of Parkinson’s later in life. The report, published in the Movement Disorders journal, used dietary information from more than 47,000 women aged 29 to 49, recorded between the early 1990s and 2012. They looked at how closely the women adhered to a Mediterranean dietary pattern (MDP), which is high in foods such as vegetables, fruits, nuts, unsaturated fats and legumes. They then compared the information with data from the Swedish National Patient Register to find out whether participants had been diagnosed with Parkinson’s. The researchers found that those with a high adherence to the diet had a 46% lower risk of being diagnosed with the condition compared to those with a low adherence, concluding that “higher adherence to a Mediterranean diet at middle age was associated with…
3 weeks ago
Pesticide that increases Parkinson’s risk by 150% reapproved in the US
The US Environmental Protection Agency (EPA) has allowed the continued use of paraquat, a pesticide that increases the risk of Parkinson’s disease by 150%. The pesticide – which has already been banned in 32 countries – was reapproved by the EPA in October as part of a review of the safety of all herbicides and pesticides in the US, a process which takes place every 15 years. Many studies have shown that as well as increased risk of Parkinson’s disease, exposure to the pesticide is associated with other health issues and risk of death. Exposure to paraquat endangers both the farmers who use the pesticide, as well as the families who can be exposed to it through the air or transfers onto clothing or other materials. In response to the reapproval, the Michael J Fox Foundation is calling on the Parkinson’s community to ask senators and representatives to support a…